首页> 外文期刊>Antimicrobial agents and chemotherapy. >Pharmacodynamic Target Attainment for Cefepime, Meropenem, and Piperacillin-Tazobactam Using a Pharmacokinetic/Pharmacodynamic-Based Dosing Calculator in Critically Ill Patients
【24h】

Pharmacodynamic Target Attainment for Cefepime, Meropenem, and Piperacillin-Tazobactam Using a Pharmacokinetic/Pharmacodynamic-Based Dosing Calculator in Critically Ill Patients

机译:使用药代动力学/药物动力学的剂量计算器在批判性患者中使用药代动力学/药物动力学的计量计算器的药效学靶标达到

获取原文
获取原文并翻译 | 示例
           

摘要

This was a prospective study to determine if pharmacokinetic/pharmacodynamic (PK/PD)-based antibiotic dosing software aids in achieving concentration targets in critically ill patients receiving cefepime (n = 10), meropenem (n = 20), or piperacillin-tazobactam (n = 19). Antibiotic calculator doses targeting a 90% probability of target attainment (PTA) differed from package insert doses for 22.4% (11/49) of patients. Target attainment was achieved for 98% of patients (48/49). A PK/PD-based antibiotic dosing calculator provides beta-lactam doses with a high PTA in critically ill patients.
机译:这是一种前瞻性研究,以确定药代动力学/药物动力学(PK / PD)的抗生素给药软件辅助在接受活性病症(n = 10),梅洛西蛋白酶(N = 20)或Piperacillin-tazobactam( n = 19)。 靶向A&gt的抗生素计算器剂量靶向A&靶培养的90%概率(PTA)不同于包装插入剂量,22.4%(11/49)患者。 98%的患者(48/49)实现了目标达成。 一种基于PK / PD的抗生素计量计算器提供β-内酰胺剂量,具有危重病患者的高PTA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号